Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients

通过多模态方法在117名日本范可尼贫血患者中鉴定出致病突变

阅读:3
作者:Minako Mori,Asuka Hira,Kenichi Yoshida,Hideki Muramatsu,Yusuke Okuno,Yuichi Shiraishi,Michiko Anmae,Jun Yasuda,Shu Tadaka,Kengo Kinoshita,Tomoo Osumi,Yasushi Noguchi,Souichi Adachi,Ryoji Kobayashi,Hiroshi Kawabata,Kohsuke Imai,Tomohiro Morio,Kazuo Tamura,Akifumi Takaori-Kondo,Masayuki Yamamoto,Satoru Miyano,Seiji Kojima,Etsuro Ito,Seishi Ogawa,Keitaro Matsuo,Hiromasa Yabe,Miharu Yabe,Minoru Takata

Abstract

Fanconi anemia is a rare recessive disease characterized by multiple congenital abnormalities, progressive bone marrow failure, and a predisposition to malignancies. It results from mutations in one of the 22 known FANC genes. The number of Japanese Fanconi anemia patients with a defined genetic diagnosis was relatively limited. In this study, we reveal the genetic subtyping and the characteristics of mutated FANC genes in Japan and clarify the genotype-phenotype correlations. We studied 117 Japanese patients and successfully subtyped 97% of the cases. FANCA and FANCG pathogenic variants accounted for the disease in 58% and 25% of Fanconi anemia patients, respectively. We identified one FANCA and two FANCG hot spot mutations, which are found at low percentages (0.04-0.1%) in the whole-genome reference panel of 3,554 Japanese individuals (Tohoku Medical Megabank). FANCB was the third most common complementation group and only one FANCC case was identified in our series. Based on the data from the Tohoku Medical Megabank, we estimate that approximately 2.6% of Japanese are carriers of disease-causing FANC gene variants, excluding missense mutations. This is the largest series of subtyped Japanese Fanconi anemia patients to date and the results will be useful for future clinical management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。